drugset / Trial / NCT03769870
Teneligliptin and Atorvastatin DDI Study
RandomizedCrossoverOpen-labelOther
Summary
A randomized, open-label, cross-over, multiple dosing study to evaluate drug-drug interaction between Teneligliptin and Atorvastatin in healthy male adults
Timeline
- Start
- 2019-01-11
- Primary completion
- 2019-02-25
- Completion
- 2019-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | — |
| Subject | Teneligliptin | Small molecule | 20 mg | — |